AI assistant
UPEXI, INC. — Director's Dealing 2022
Apr 1, 2022
33031_dirs_2022-04-01_94e7c57c-c463-4cb6-8766-88b044c511dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GROVE, INC. (GRVI)
CIK: 0001775194
Period of Report: 2022-03-30-05:00
Reporting Person: Salkind Gene (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-30-05:00 | Common Stock | P | 125000 | $4.00 | Acquired | 125000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2352942 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option Grant | $1.53 | 2031-02-21-05:00 | Common (27778) | 27778 | Direct |
| Option Grant | $4.18 | 2032-02-21-05:00 | Common (50000) | 50000 | Direct |
Footnotes
F1: 125,000 shares were purchased at $4.00 per share in a private transaction through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee and considered indirect ownership of Gene Salkind
F2: 27,778 options are vested and shall be exercisable for a price of $1.53 for 10 years from February 1, 2021 (the "Grant Date")
F3: 16,667 options are vested and shall be exercisable for a price of $4.18 for 10 years from July 21, 2022 (the "Grant Date"). 33,333 options share vest on a monthly basis over a two year period and exercisable for a price of $4.18 per option share for a ten year period of 10 years from the Grant Date.
F4: 2,352,941 previously purchased and are jointly owned with Catherine Salkind.